Literature DB >> 26080650

Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes.

Melanie Cree-Green1,2,3, David M Maahs1, Annie Ferland4, John E Hokanson4, Hong Wang4, Laura Pyle2, Gregory L Kinney2,5, Martina King4, Robert H Eckel4, Kristen J Nadeau1,2,3.   

Abstract

AIMS/HYPOTHESIS: Adolescents with type 1 diabetes (T1D) often have a less atherogenic-appearing fasting lipid profile than controls, despite increased rates of cardiovascular disease (CVD) as adults. We previously reported an atherogenic lipoprotein subfraction cholesterol distribution associated with insulin resistance (IR) in T1D adults. We sought to determine if T1D youth have more atherogenic profile than controls via a cross-sectional study.
METHODS: Following 3 days of controlled diet and restricted exercise, fasting plasma samples were drawn from 28 T1D youth [50% female, age 15.3 ± 2 yr, body mass index (BMI) 48%ile; diabetes duration 73 ± 52 months, hemoglobin A1c (HbA1c) 8.3 ± 1.4%] and 17 non-diabetic controls (47% female, age: 15.0 ± 2 yr, BMI 49%ile) prior to a hyperinsulinemic euglycemic clamp. Lipoproteins were fractionated by fast protein liquid chromatography (FPLC) and lipoprotein cholesterol distribution determined. Outcome measures were IR assessed by glucose infusion rate (GIR) and FPLC lipoprotein subfraction cholesterol distribution.
RESULTS: T1D youth were more IR (GIR 9.1 ± 3.6 vs. 14.7 ± 3.9 mg/kg/min, p < 0.0001) and had more cholesterol distributed as small dense low density lipoprotein-cholesterol (LDL-C) and less as large buoyant high density lipoprotein-cholesterol (HDL-C) than controls (p < 0.05), despite no differences in the fasting lipid panel. T1D girls lacked the typical female less-atherogenic profile, whereas control girls tended to have a shift toward less dense LDL-C and HDL-C vs. control boys. Among T1D, IR but not HbA1c was associated with a more atherogenic lipoprotein profile. CONCLUSIONS/INTERPRETATIONS: Normal weight T1D youth, especially females, had more atherogenic LDL-C and HDL-C distributions which correlated with lower insulin sensitivity. IR may contribute to the increased CVD burden in T1D.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiovascular disease; insulin resistance; lipids; pediatrics; type 1 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26080650      PMCID: PMC4887262          DOI: 10.1111/pedi.12277

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  50 in total

1.  Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus.

Authors:  David M Maahs; Aristides K Maniatis; Kristen Nadeau; R Paul Wadwa; Kim McFann; Georgeanna J Klingensmith
Journal:  J Pediatr       Date:  2005-10       Impact factor: 4.406

2.  The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification.

Authors:  H M Colhoun; M B Rubens; S R Underwood; J H Fuller
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

3.  Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.

Authors:  S P Laing; A J Swerdlow; S D Slater; A C Burden; A Morris; N R Waugh; W Gatling; P J Bingley; C C Patterson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

4.  Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus.

Authors:  J D Bagdade; F L Dunn; R H Eckel; M C Ritter
Journal:  Arterioscler Thromb       Date:  1994-12

5.  Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study.

Authors:  Kristen J Nadeau; Kelsey Chow; Suhyla Alam; Kara Lindquist; Sarah Campbell; Kim McFann; Georgeanna Klingensmith; Phillipe Walravens
Journal:  Pediatr Diabetes       Date:  2014-04-03       Impact factor: 4.866

6.  Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes.

Authors:  David M Maahs; Dana Dabelea; Ralph B D'Agostino; Jeannette S Andrews; Amy S Shah; Nancy Crimmins; Elizabeth J Mayer-Davis; Santica Marcovina; Giuseppina Imperatore; R Paul Wadwa; Steven R Daniels; Kristi Reynolds; Richard F Hamman; Lawrence M Dolan
Journal:  J Pediatr       Date:  2012-07-11       Impact factor: 4.406

7.  Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes.

Authors:  A Thankamony; P H Tossavainen; A Sleigh; C Acerini; D Elleri; R N Dalton; N C Jackson; A M Umpleby; R M Williams; D B Dunger
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

8.  Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment.

Authors:  Alina C R Feitosa; Gilson S Feitosa-Filho; Fatima R Freitas; Bernardo L Wajchenberg; Raul C Maranhão
Journal:  Lipids Health Dis       Date:  2013-02-11       Impact factor: 3.876

9.  Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.

Authors:  J Q Purnell; J E Hokanson; S M Marcovina; M W Steffes; P A Cleary; J D Brunzell
Journal:  JAMA       Date:  1998-07-08       Impact factor: 157.335

10.  Cardiovascular risk factors are associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study.

Authors:  Dana Dabelea; Jennifer W Talton; Ralph D'Agostino; R Paul Wadwa; Elaine M Urbina; Lawrence M Dolan; Stephen R Daniels; Santica M Marcovina; Richard F Hamman
Journal:  Diabetes Care       Date:  2013-10-07       Impact factor: 19.112

View more
  16 in total

1.  Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.

Authors:  Melanie Cree-Green; Bryan C Bergman; Eda Cengiz; Larry A Fox; Tamara S Hannon; Kellee Miller; Brandon Nathan; Laura Pyle; Darcy Kahn; Michael Tansey; Eileen Tichy; Eva Tsalikian; Ingrid Libman; Kristen J Nadeau
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus.

Authors:  Petter Bjornstad; Michal Schäfer; Uyen Truong; Melanie Cree-Green; Laura Pyle; Amy Baumgartner; Yesenia Garcia Reyes; Aristides Maniatis; Sunil Nayak; R Paul Wadwa; Lorna P Browne; Jane E B Reusch; Kristen J Nadeau
Journal:  Circulation       Date:  2018-12-18       Impact factor: 29.690

3.  Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Authors:  Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green
Journal:  Vasc Med       Date:  2017-01-17       Impact factor: 3.239

4.  Youth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance.

Authors:  Melanie Cree-Green; Jacob J Stuppy; Jessica Thurston; Bryan C Bergman; Gregory V Coe; Amy D Baumgartner; Samantha Bacon; Ann Scherzinger; Laura Pyle; Kristen J Nadeau
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

Review 5.  Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Authors:  Petter Bjornstad; Robert H Eckel
Journal:  Curr Diab Rep       Date:  2018-10-17       Impact factor: 4.810

Review 6.  Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control.

Authors:  Rachel G Miller; Tina Costacou
Journal:  Curr Cardiol Rep       Date:  2022-08-10       Impact factor: 3.955

Review 7.  Lipid management for cardiovascular risk reduction in type 1 diabetes.

Authors:  Shoshana Tell; Kristen J Nadeau; Robert H Eckel
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-08       Impact factor: 3.626

Review 8.  Cardiovascular disease in diabetes, beyond glucose.

Authors:  Robert H Eckel; Karin E Bornfeldt; Ira J Goldberg
Journal:  Cell Metab       Date:  2021-07-21       Impact factor: 31.373

9.  Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes.

Authors:  Talia L Brown; David M Maahs; Franziska K Bishop; Janet K Snell-Bergeon; R Paul Wadwa
Journal:  Int J Pediatr Endocrinol       Date:  2016-04-19

10.  Effect of metformin on the high-density lipoprotein proteome in youth with type 1 diabetes.

Authors:  Evgenia Gourgari; Kristen J Nadeau; Laura Pyle; Martin P Playford; Junfeng Ma; Nehal N Mehta; Alan T Remaley; Scott M Gordon
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.